RE:Hypothetical Buyhigheatchips wrote: What happens if someone offers us $2 a share on the basis of GG and the extraction tech? Many shareholders may be happy with that but the company doesn't want to give away the specialty molecule IP. How to navigate such a situation?
One thought I had is that another corporation is set up to hold a certain percentage of royalties on that IP and each shareholder gets shares in that corp as part of the deal.
The other option is to hold out until the speciality molecule IP has been more developed I suppose.
What do y'all think?
I would take the $2 a share price as that's 12X from where we sit today. I have been invested in Nextleaf for 12 months or so, so that would be a good return for me.
I just don't think Paul would sell at that price as a $2 price puts OILS at a $250-$300M market cap. This is no where near his claims of the $1B patent portfolio he loves to tout. But if he was being offered $500M market cap or above, I would hope he would take it as that's a hefty premium from where we sit today.